Largest Genetic Study of Sleep Identifies 20 New Loci and Sex-Specific Sleep Regulators
Key Takeaways
- ▸Study of 80,013 participants identified 20 genetic loci associated with sleep traits, with 12 previously unknown to science
- ▸MEIS1 gene shows critical role in balancing REM and NREM sleep phases with opposing effects on each
- ▸Sex-specific genetic differences found in sleep regulation, with distinct loci in males versus females
Summary
Researchers have completed the largest genome-wide association study (GWAS) of sleep traits, analyzing wearable device data from over 80,000 UK Biobank participants to identify the genetic architecture of sleep duration, efficiency, and REM/NREM sleep phases. The study identified 20 autosomal loci associated with sleep characteristics, with 12 being previously unreported, including the first genome-wide significant associations for REM and NREM sleep duration specifically. A key finding involves the MEIS1 gene, which shows opposing effects on REM and NREM sleep duration and appears essential for maintaining the balance between sleep phases.
The research reveals important biological pathways and tissue-specific signals underlying sleep regulation. Functional analysis identified statistically significant pathways related to chromatin remodelling, lipid metabolism, and metal ion homeostasis, while tissue enrichment analysis highlighted the hypothalamus and frontal cortex as critical regions. Notably, sex-stratified analyses uncovered distinct genetic loci between males and females, with genes like FOXP2 and NRXN3 significant in females and LRP1B, NPBWR2, and PABPC4 in males, indicating that sleep regulation has important sex-specific components.
Mendelian randomization analyses provided evidence supporting associations between shorter sleep duration and increased cardiometabolic risk, suggesting potential therapeutic implications. These findings offer new biological insights into how sleep is regulated and identify potential drug targets for sleep disorders and related health conditions.
- Shorter sleep duration genetically associated with higher cardiometabolic risk via Mendelian randomization
- Key biological pathways identified include chromatin remodelling, lipid metabolism, and hypothalamus/frontal cortex involvement
Editorial Opinion
This comprehensive GWAS represents a significant advance in understanding the genetic basis of sleep, moving beyond previous studies with its focus on device-measured sleep phases rather than self-reported metrics. The discovery of sex-specific sleep regulators is particularly noteworthy, as it challenges one-size-fits-all approaches to sleep research and treatment. These findings could accelerate development of targeted therapeutics for sleep disorders and establish sleep genetics as a key window into cardiometabolic health.
